Cargando…

Reversible istradefylline-induced pleurothotonus in a patient with Parkinson's disease: A case report and literature review

Pleurothotonus, commonly known as Pisa syndrome (PS), is characterized by abnormal lateral flexion of the trunk. The precise mechanism of this disease is unknown. Istradefylline was administered to a 68-year-old male patient with Parkinson's disease (PD) to treat wearing-off; however, PS appear...

Descripción completa

Detalles Bibliográficos
Autor principal:	Yasuda, Yuzuru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153187/ https://www.ncbi.nlm.nih.gov/pubmed/30258991 http://dx.doi.org/10.1016/j.ensci.2018.09.001

Ejemplares similares

The effect of istradefylline for Parkinson’s disease: A meta-analysis
por: Sako, Wataru, et al.
Publicado: (2017)

Istradefylline for Restless Legs Syndrome Associated with Parkinson’s Disease
por: Nuermaimaiti, Maierdanjiang, et al.
Publicado: (2018)

Istradefylline to Treat Patients with Parkinson’s Disease Experiencing “Off” Episodes: A Comprehensive Review
por: Berger, Amnon A., et al.
Publicado: (2020)

Istradefylline Improves Impaired Smooth Pursuit Eye Movements in Parkinson’s Disease
por: Fujita, Youshi, et al.
Publicado: (2023)

Istradefylline Versus Opicapone for “Off” Episodes in Parkinson’s Disease: A Systematic Review and Meta-Analysis
por: Singh, Alok, et al.
Publicado: (2021)

Istradefylline for OFF Episodes in Parkinson’s Disease: A US Perspective of Common Clinical Scenarios
por: Isaacson, Stuart H, et al.
Publicado: (2022)

Adenosine A(2A) Receptor Occupancy by Long‐Term Istradefylline Administration in Parkinson's Disease
por: Ishibashi, Kenji, et al.
Publicado: (2020)

Adenosine A(2A) receptor antagonist istradefylline reduces daily OFF time in Parkinson’s disease
por: Mizuno, Yoshikuni, et al.
Publicado: (2013)

A Pooled Analysis From Phase 2b and 3 Studies in Japan of Istradefylline in Parkinson's Disease
por: Hattori, Nobutaka, et al.
Publicado: (2020)

Istradefylline: A novel agent in the treatment of “off” episodes associated with levodopa/carbidopa use in Parkinson disease
por: Cummins, Lauren, et al.
Publicado: (2022)

Separation and identification of an impurity from the istradefylline intermediate
por: Xu, Haojie, et al.
Publicado: (2020)

Effects of Rifampin on the Pharmacokinetics of a Single Dose of Istradefylline in Healthy Subjects
por: Mukai, Mayumi, et al.
Publicado: (2017)

Istradefylline effects on tremor dominance (TD) and postural instability and gait difficulty (PIGD)
por: Torres-Yaghi, Yasar, et al.
Publicado: (2023)

Unusually Severe Bout in a Patient With a History of Cluster Headache Associated With COVID-19: A Case Report and Review of the Literature
por: Yasuda, Yuzuru, et al.
Publicado: (2023)

Istradefylline protects from cisplatin-induced nephrotoxicity and peripheral neuropathy while preserving cisplatin antitumor effects
por: Dewaeles, Edmone, et al.
Publicado: (2022)

Evaluating the impact of adjunctive istradefylline on the cumulative dose of levodopa-containing medications in Parkinson’s disease: study protocol for the ISTRA ADJUST PD randomized, controlled study
por: Hatano, Taku, et al.
Publicado: (2022)

Efficacy of Istradefylline, an Adenosine A(2A) Receptor Antagonist, as Adjunctive Therapy to Levodopa in Parkinson’s Disease: A Pooled Analysis of 8 Phase 2b/3 Trials
por: Hauser, Robert A., et al.
Publicado: (2021)

Istradefylline Mitigates Age-Related Hearing Loss in C57BL/6J Mice
por: Shin, Min, et al.
Publicado: (2021)

Design, Synthesis, and Biological Activity Studies of Istradefylline Derivatives Based on Adenine as A(2A) Receptor Antagonists
por: Wang, Yiyun, et al.
Publicado: (2021)

Straight sinus dural arteriovenous fistula presenting with reversible parkinsonism: A case report and literature review
por: Pu, Jiali, et al.
Publicado: (2017)

Parkinson's Disease in Pregnancy: A Case Report and Review of the Literature
por: Olivola, Sara, et al.
Publicado: (2020)

Clozapine use in drug induced psychosis in Parkinson´s disease: a case report and review of literature.
por: Sanz Giancola, A., et al.
Publicado: (2023)

Takayasu's arteritis: Is it a reversible disease? Case Report and Literature Review
por: Hedna, Vishnumurthy Shushrutha, et al.
Publicado: (2012)

Clinically reversible ustekinumab-induced encephalopathy: case report and review of the literature
por: Sarto, Jordi, et al.
Publicado: (2022)

Reversible posterior leukoencephalopathy syndrome induced by apatinib: a case report and literature review
por: Li, Xutong, et al.
Publicado: (2018)

Chlorfenapyr-Induced Toxic Leukoencephalopathy with Radiologic Reversibility: A Case Report and Literature Review
por: Baek, Byung Hyun, et al.
Publicado: (2016)

PS55. Parkinsonism induced by valproic acid: a case report and review of literature
por: TADA, Haruka, et al.
Publicado: (2016)

Parkinsonism-hyperpyrexia syndrome: A case report and review of literature
por: Grover, Sandeep, et al.
Publicado: (2018)

Rhabdomyolysis Associated with Severe Levodopa-Induced Dyskinesia in Parkinson’s Disease: A Report of Two Cases and Literature Review
por: Pitakpatapee, Yuvadee, et al.
Publicado: (2021)

Pimavanserin in Parkinson’s Disease-induced Psychosis: A Literature Review
por: Patel, Rikinkumar S, et al.
Publicado: (2019)

Progressive Supranuclear Palsy Misdiagnosed as Parkinson's Disease: A Case Report and Review of Literature
por: Owolabi, LF
Publicado: (2013)

Fast Orthostatic Tremor in Parkinson’s Disease: Case Report and Comprehensive Review of Literature
por: Chaithra, Sudhakar Pushpa, et al.
Publicado: (2019)

Extrapyramidal syndromes of chronic kidney disease and dialysis (diabetic uremic syndrome) with reversible parkinsonism and lentiform fork sign: A case report and literature review including metformin-induced encephalopathy
por: Sakurai, Takeo, et al.
Publicado: (2023)

Pramipexole-induced antecollis in patients with Parkinson's disease: Two cases and literature review
por: Iijima, Mutsumi, et al.
Publicado: (2015)

Hypothyroidism-induced Reversible Encephalopathy as a Cause of Aggravation of Parkinsonism and Myoclonus in Parkinson’s Disease
por: Ehm, Gwanhee, et al.
Publicado: (2017)

Alectinib (Alecensa)-induced reversible grade IV nephrotoxicity: a case report and review of the literature
por: Ramachandran, P, et al.
Publicado: (2018)

Triptan-induced Reversible Cerebral Vasoconstriction Syndrome: Two Case Reports with a Literature Review
por: Kato, Yuji, et al.
Publicado: (2016)

Gemcitabine and Cisplatin induced posterior reversible encephalopathy syndrome: A case report with review of literature
por: Kabre, Rohit Santosh, et al.
Publicado: (2016)

A unique case report of jejunoileal bypass reversal with review of the literature
por: Justice, Ashlee, et al.
Publicado: (2018)

Reverse takotsubo cardiomyopathy: two case reports and review of the literature
por: Patankar, Gautam R, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7lvh7olr409bkb94onjdvlv800